|

Prednisone/ prednisolone Clinical Trials

7 actively recruiting trials across 7 locations

▲ +1 trial since July 2026

Also known as: Deltasone/Omnipred, Deltasone®/OMNIPRED®, Prednisolone

Pipeline

Phase 2: 1Phase 3: 5Phase 4: 1

Top Sponsors

  • Regeneron Pharmaceuticals2
  • Janssen Research & Development, LLC1
  • Celgene1
  • BioNTech SE1
  • AstraZeneca1

Indications

  • Cancer7
  • Metastatic Castration-resistant Prostate Cancer2
  • Prostatic Neoplasms, Castration-Resistant1
  • gMG1
  • Follicular Lymphoma ( FL)1

Birmingham, Alabama1 trial

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Local Institution - 0225

Phase 3

Chandler, Arizona1 trial

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Arizona Clinical Trials

Phase 3

Scottsdale, Arizona1 trial

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Mayo Clinic - Arizona

Phase 3

Tucson, Arizona1 trial

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

University of Arizona Cancer Center

Phase 3

Los Angeles, California1 trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site

Phase 2

Aurora, Colorado1 trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Rocky Mountain Cancer Centers

Phase 3

Chicago, Illinois1 trial

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Research Site

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.